The glomerular transcriptome sequencing of various glomerular diseases, including membranous nephropathy (MN), focal segmental glomerulosclerosis (FSGS), and minimal change disease (MCD) confirmed that the transcriptional level of PTGDS was significantly decreased (Figure 4H). This evidence concerns the gene PTGDS and focal segmental glomerulosclerosis.